GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (OTCPK:POLBF) » Definitions » YoY EBITDA Growth

POLBF (Poolbeg Pharma) YoY EBITDA Growth : -20.00% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Poolbeg Pharma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Poolbeg Pharma's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was -20.00%.

Poolbeg Pharma's EBITDA per Share for the six months ended in Jun. 2024 was $-0.01.

Poolbeg Pharma YoY EBITDA Growth Historical Data

The historical data trend for Poolbeg Pharma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma YoY EBITDA Growth Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23
YoY EBITDA Growth
- -20.00 -

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial - - -25.00 12.50 -20.00

Poolbeg Pharma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Poolbeg Pharma's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.012--0.012)/ | -0.012 |
=0.00 %

Poolbeg Pharma's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(-0.006--0.005)/ | -0.005 |
=-20.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poolbeg Pharma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (OTCPK:POLBF) » Definitions » YoY EBITDA Growth
Comparable Companies
LSE:AREC LSE:OPTI AQSE:PBX LSE:IMM LSE:IXI LSE:OBD LSE:SAR LSE:HEMO LSE:FAB AQSE:INC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
POLB:UK 7JN:Germany
Address
42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX
Website
https://www.poolbegpharma.com
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.